Delphine Le Louet
Stock Analyst at Bernstein
(0.36)
# 4,202
Out of 4,476 analysts
175
Total ratings
42%
Success rate
-7%
Average return
Main Sectors:
Stocks Rated by Delphine Le Louet
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ETR: GXI Gerresheimer AG | Upgraded: Hold | €18.90 → €28.70 | $28.14 | +1.99% | 14 | Jul 1, 2026 | |
| ETR: SRT3 Sartorius Aktiengesellschaft | Maintained: Buy | €284.00 | $226.60 | +25.33% | 20 | Apr 23, 2026 | |
| AMS: LKFT Lakefront Biotherapeutics NV | Maintained: Hold | €27.90 | $26.90 | +3.72% | 2 | Mar 31, 2026 | |
| SWX: TECN Tecan Group AG | Upgraded: Hold | CHF 165.20 → CHF 156.00 | $176.90 | -11.81% | 2 | Jan 16, 2026 | |
| STO: GETI.B Getinge AB (publ) | Initiated Coverage: Hold | kr 228.00 | $208.00 | n/a | 1 | Jun 17, 2025 | |
| EPA: DIM Sartorius Stedim Biotech S.A. | Maintained: Hold | €172.00 → €234.00 | $180.20 | n/a | 14 | Apr 16, 2025 | |
| EPA: ERF Eurofins Scientific SE | Maintained: Hold | €52.80 → €53.80 | $69.36 | n/a | 7 | Nov 28, 2024 | |
| EPA: DBV DBV Technologies S.A. | Maintained: Buy | €5.70 → €3.03 | $2.89 | n/a | 10 | Mar 17, 2024 | |
| SWX: ALC Alcon Inc. | Maintained: Hold | CHF 77.60 → CHF 72.20 | $55.04 | n/a | 16 | Feb 29, 2024 | |
| EPA: IPN Ipsen S.A. | Maintained: Buy | €142.00 → €150.40 | $170.70 | n/a | 14 | Jan 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €20.30 → €13.60 | $3.42 | n/a | 9 | Dec 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €57.00 → €57.10 | $34.97 | n/a | 7 | Nov 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €20.10 → €18.95 | $24.69 | n/a | 12 | Oct 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | €186.40 → €189.80 | $172.20 | n/a | 19 | Oct 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €103.00 → €101.00 | $69.70 | n/a | 15 | Sep 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $27.74 | n/a | 2 | Oct 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | €579.00 → €612.00 | $187.40 | n/a | 6 | Jan 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | $13 | $15.82 | n/a | 4 | May 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | $145 | $100.03 | n/a | 1 | Oct 8, 2020 |
Gerresheimer AG
Jul 1, 2026
Upgraded: Hold
Price Target: €18.90 → €28.70
Current: $28.14
Upside: +1.99%
Sartorius Aktiengesellschaft
Apr 23, 2026
Maintained: Buy
Price Target: €284.00
Current: $226.60
Upside: +25.33%
Lakefront Biotherapeutics NV
Mar 31, 2026
Maintained: Hold
Price Target: €27.90
Current: $26.90
Upside: +3.72%
Tecan Group AG
Jan 16, 2026
Upgraded: Hold
Price Target: CHF 165.20 → CHF 156.00
Current: $176.90
Upside: -11.81%
Getinge AB (publ)
Jun 17, 2025
Initiated Coverage: Hold
Price Target: kr 228.00
Current: $208.00
Upside: n/a
Sartorius Stedim Biotech S.A.
Apr 16, 2025
Maintained: Hold
Price Target: €172.00 → €234.00
Current: $180.20
Upside: n/a
Eurofins Scientific SE
Nov 28, 2024
Maintained: Hold
Price Target: €52.80 → €53.80
Current: $69.36
Upside: n/a
DBV Technologies S.A.
Mar 17, 2024
Maintained: Buy
Price Target: €5.70 → €3.03
Current: $2.89
Upside: n/a
Alcon Inc.
Feb 29, 2024
Maintained: Hold
Price Target: CHF 77.60 → CHF 72.20
Current: $55.04
Upside: n/a
Ipsen S.A.
Jan 3, 2024
Maintained: Buy
Price Target: €142.00 → €150.40
Current: $170.70
Upside: n/a
Dec 22, 2023
Maintained: Buy
Price Target: €20.30 → €13.60
Current: $3.42
Upside: n/a
Nov 13, 2023
Maintained: Buy
Price Target: €57.00 → €57.10
Current: $34.97
Upside: n/a
Oct 24, 2023
Maintained: Hold
Price Target: €20.10 → €18.95
Current: $24.69
Upside: n/a
Oct 20, 2023
Upgraded: Buy
Price Target: €186.40 → €189.80
Current: $172.20
Upside: n/a
Sep 29, 2023
Maintained: Hold
Price Target: €103.00 → €101.00
Current: $69.70
Upside: n/a
Oct 13, 2022
Downgraded: Hold
Price Target: n/a
Current: $27.74
Upside: n/a
Jan 28, 2022
Upgraded: Buy
Price Target: €579.00 → €612.00
Current: $187.40
Upside: n/a
May 4, 2021
Upgraded: Hold
Price Target: $13
Current: $15.82
Upside: n/a
Oct 8, 2020
Upgraded: Hold
Price Target: $145
Current: $100.03
Upside: n/a